Skip to main content

Find Clinical Trials

Home
Conditions
Non-Hodgkin's Lymphoma

Clinical trial condition

Non-Hodgkin's Lymphoma

Explore clinical trials studying Non-Hodgkin's Lymphoma. Study availability and eligibility vary by location and protocol.

250 public trials 20 recruiting studies

Refine in advanced search Browse all conditions

Non-Hodgkin's Lymphoma trial results

Recruiting

Comparison Study of EAP and Disease-Specific Chemotherapy Regimens in Hematopoietic Stem Cell Mobilization for Lymphoma

NCT06520163

Conditions: Hematopoietic Stem Cell Mobilization, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
Locations: Dongyang People's Hospital Dongyang, Zhejiang, China

The Affiliated Hangzhou First People's Hospital Hangzhou, Zhejiang, China

The First Affiliated Hospital, College of Medicine, Zhejiang University Hangzhou, Zhejiang, China

Tongde Hospital of Zhejiang Province Hangzhou, Zhejiang, China

View all 17 locations

View Trial Details

Recruiting

ID Of Prognostic Factors In Mycosis Fungoides/Sezary Syndrome

NCT02848274

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +10 more
Locations: City of Hope Duarte, California, United States

Stanford University, School of Medicine Palo Alto, California, United States

University of Iowa Iowa City, Iowa, United States

Hackensack University Medical Center Hackensack, New Jersey, United States

View all 13 locations

View Trial Details

Recruiting

Role of Antibiotic Therapy or Immunoglobulin On iNfections in hAematoLogy Platform Trial (RATIONAL-PT)

NCT07202052

Conditions: Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +12 more
Locations: Royal Adelaide Hospital Adelaide, South Australia, Australia

Austin Hospital Melbourne, Victoria, Australia

Northern Health Melbourne, Victoria, Australia

View Trial Details

Recruiting

CLIC-1901 for the Treatment of Patients With Relapsed/Refractory CD19 Positive Hematologic Malignancies

NCT03765177

Conditions: Acute Lymphoblastic Leukemia, Chronic Disease, Chronic Lymphocytic Leukemia, +19 more
Locations: Vancouver General Hospital Vancouver, British Columbia, Canada

CancerCare Manitoba Winnipeg, Manitoba, Canada

The Ottawa Hospital - General Campus Ottawa, Ontario, Canada

View Trial Details

Recruiting

T-Cell Therapy (EB103) in Adults With Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma (NHL)

NCT06343311

Conditions: B-Cell Non-Hodgkin's Lymphoma (NHL), CNS Lymphoma, HIV Associated Lymphoma, +21 more
Locations: University of California, Davis Sacramento, California, United States

Baylor Scott & White Research Institute, Texas Oncology Dallas, Texas, United States

View Trial Details

Recruiting

Phase II Clinical Trial of CNCT19 Cell Injection in the Treatment of Relapsed or Refractory Non-Hodgkin's Lymphoma

NCT04586478

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
Locations: Beijing Boren Hospital Beijing, Beijing Municipality, China

Beijing Cancer Hospital Beijing, Beijing Municipality, China

Peking University Third Hospital Beijing, Beijing Municipality, China

The First Affiliated Hospital of Chongqing Medical University Chongqing, Chongqing Municipality, China

View all 17 locations

View Trial Details

Recruiting

A Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Efficacy Study of MBS303 in B-Cell NHL

NCT05806099

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
Locations: Beijing Cancer Hospital Beijing, China

View Trial Details

Recruiting

CD 70 CAR T for Patients With CD70 Positive Malignant Hematologic Diseases

NCT04662294

Conditions: Acute Myeloid Leukemia, Blood Protein Disorders, Cardiovascular Diseases, +20 more
Locations: The first affiliated hospital of medical college of zhejiang university Hangzhou, Zhejiang, China

View Trial Details

Recruiting

A Study of CAR-T Cells Therapy for Patients With Relapsed and/or Refractory Central Nervous System Hematological Malignancies

NCT04532203

Conditions: Acute Lymphoblastic Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +12 more
Locations: The First Affiliated Hospital，College of Medicine, Zhejiang University Hangzhou, Zhejiang, China

View Trial Details

Recruiting

CD30-directed Chimeric Antigen Receptor T (CART30) Therapy in Relapsed and Refractory CD30 Positive Lymphomas

NCT02259556

Conditions: Hemic and Lymphatic Diseases, Hodgkin Disease, Hodgkin's Lymphoma, +9 more
Locations: Chinese PLA General Hospital Beijing, Beijing Municipality, China

View Trial Details